Investing.com - BMO Capital已将Structure Therapeutics (NASDAQ:GPCR)的目标价从100.00美元上调至130.00美元，同时维持对该股的"优于大市"评级。新目标价较当前69.98美元的价格有显著上涨空间，而GPCR股票在过去六个月已展现出显著的增长势头，上涨了241.2%。InvestingPro数据显示，该股票倾向于与更广泛的市场趋势相 ...

Monday was quite the day for biotech companies developing the next generation of obesity drugs. One of them, Structure ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

There are a number of factors that differentiate small-business operations from large-business operations, one of which is the implementation of a formal organizational structure. Organizational ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Arguably, one of the most complicated topics for any business is how to structure an ...